Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Marker Therapeutics (MRKR) Q2 2025 Earnings
MRKR
16
May
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.53
-0.44
-0.34
-0.25
Details
Expected EPS
-0.53017
Actual EPS
-0.4
Surprise EPS
0.13
Surprise Percent
+24.55%
Description
Marker Therapeutics (MRKR) has reported earnings of -0.4 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login